Exscientia PLC (EXAI)
5.17
+0.04
(+0.78%)
USD |
NASDAQ |
May 17, 16:00
5.18
+0.01
(+0.19%)
Pre-Market: 20:00
Exscientia Total Liabilities (Quarterly): 197.45M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 197.45M |
| September 30, 2023 | 191.75M |
| June 30, 2023 | 184.99M |
| March 31, 2023 | 192.67M |
| December 31, 2022 | 206.66M |
| September 30, 2022 | 180.54M |
| Date | Value |
|---|---|
| June 30, 2022 | 197.68M |
| March 31, 2022 | 217.19M |
| December 31, 2021 | 99.67M |
| September 30, 2021 | 101.20M |
| June 30, 2021 | 68.38M |
| December 31, 2020 | 26.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
26.17M
Minimum
Dec 2020
217.19M
Maximum
Mar 2022
155.36M
Average
188.37M
Median
Total Liabilities (Quarterly) Benchmarks
| Akero Therapeutics Inc | 65.99M |
| AstraZeneca PLC | 64.79B |
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| Verona Pharma PLC | 64.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 650.61M |
| Shareholders Equity (Quarterly) | 453.16M |
| Debt to Equity Ratio | 0.0009 |
| Current Ratio | 6.223 |
| Net Debt Paydown Yield | -0.00% |